Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth 2019-2024

Published On: Mar 2019

Format: PDF

Publisher: LP infomation

Pages: 136

Report ID: 236751

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.


According to this study, over the next five years the ICAD (Intracranial Atherosclerotic Disease) Pathology market will register a 8.7% CAGR in terms of revenue, the global market size will reach US$ 220 million by 2024, from US$ 130 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in ICAD (Intracranial Atherosclerotic Disease) Pathology business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of ICAD (Intracranial Atherosclerotic Disease) Pathology market by product type, application, key manufacturers and key regions and countries.

This study considers the ICAD (Intracranial Atherosclerotic Disease) Pathology value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
primarily split into
Stent
PTA Balloon
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Stryker
Balt
TERUMO
MicroPort
Acandis
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global ICAD (Intracranial Atherosclerotic Disease) Pathology consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of ICAD (Intracranial Atherosclerotic Disease) Pathology market by identifying its various subsegments.
Focuses on the key global ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the ICAD (Intracranial Atherosclerotic Disease) Pathology with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of ICAD (Intracranial Atherosclerotic Disease) Pathology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2014-2024
2.1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption CAGR by Region
2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
2.2.1 primarily split into
2.2.2 Stent
2.2.3 PTA Balloon
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
2.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type (2014-2019)
2.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Type (2014-2019)
2.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Type (2014-2019)
2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
2.5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application (2014-2019)
2.5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value and Market Share by Application (2014-2019)
2.5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Application (2014-2019)

3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Players
3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Players
3.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Players (2017-2019)
3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Players (2017-2019)
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Players
3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Players (2017-2019)
3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Players (2017-2019)
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Players
3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ICAD (Intracranial Atherosclerotic Disease) Pathology by Regions
4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology by Regions
4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Regions
4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Regions
4.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth
4.3 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth
4.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth
4.5 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth

5 Americas
5.1 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries
5.1.1 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2014-2019)
5.1.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2014-2019)
5.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
5.3 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries
6.1.1 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2014-2019)
6.1.2 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2014-2019)
6.2 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
6.3 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
7.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2014-2019)
7.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2014-2019)
7.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
8.1.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2014-2019)
8.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
8.3 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
10.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customer

11 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast
11.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2019-2024)
11.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Regions
11.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Regions (2019-2024)
11.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Type
11.8 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Application

12 Key Players Analysis
12.1 Stryker
12.1.1 Company Details
12.1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
12.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Stryker News
12.2 Balt
12.2.1 Company Details
12.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
12.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Balt News
12.3 TERUMO
12.3.1 Company Details
12.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
12.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 TERUMO News
12.4 MicroPort
12.4.1 Company Details
12.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
12.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 MicroPort News
12.5 Acandis
12.5.1 Company Details
12.5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
12.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Acandis News
...

13 Research Findings and Conclusion